MAPT and Alzheimer disease: As a systematic review with meta-analysis indicated in this study, Icariin treatment could improve memory and learning function by decreasing the expression of Aβ1-40, Aβ1-42, BACE1, tau, and hyperphosphorylated tau, which are critical mediators for the progression of AD.